Yet another reason to use leronlimab for COVID-19.
Post# of 153778
(Total Views: 874)
Posted On: 06/07/2021 6:04:55 PM
Yet another reason to use leronlimab for COVID-19.
https://www.frontiersin.org/articles/10.3389/...92891/full
Quote:
dormant cancer cells (DCCs). DCCs often survive treatment of primary tumors and populate premetastatic niches in the lungs and other organs, retaining the potential for metastatic outgrowth. DCCs reawakening may be promoted by several events associated to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including activation of neutrophils and monocytes/macrophages, lymphopenia and an uncontrolled production of pro-inflammatory cytokines. Among pro-inflammatory factors produced during COVID-19, neutrophil extracellular traps (NETs) released by activated neutrophils have been specifically shown to activate premetastatic cancer cells disseminated in the lungs, suggesting they may be involved in DCCs reawakening in COVID-19 patients.
https://www.frontiersin.org/articles/10.3389/...92891/full
(10)
(1)